Tongshu Gene Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$14.2M
- Investors
-
11
Tongshu Gene General Information
Description
Provider of gene testing services intended to improve tumor precision medicine. The company develops diagnostic molecular pathology projects and ctDNA precision detection systems based on high-throughput gene sequencing technology and biological information analysis, providing clinicians with consulting services including precision medication, efficacy monitoring, postoperative recurrence monitoring, risk prediction and early detection.
Contact Information
Website
www.tongshugene.netCorporate Office
- 2nd Floor, Building B2
- No. 9 Changyang Road, Xitaihu Science and Technology Industrial Park
- Changzhou, Jiangsu
- China
Corporate Office
- 2nd Floor, Building B2
- No. 9 Changyang Road, Xitaihu Science and Technology Industrial Park
- Changzhou, Jiangsu
- China
Tongshu Gene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series D) | 14-Oct-2024 | $14.2M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series C) | 15-Jun-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 22-Sep-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 01-Feb-2018 | Completed | Generating Revenue |
Tongshu Gene Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Bohua Capital | Venture Capital | Minority | ||
| China Galaxy Securities | Corporation | Minority | ||
| GL Capital Group | Growth/Expansion | Minority | ||
| Haier Financial Holdings | Fund of Funds | Minority | ||
| Haier Group | Corporation | Minority |
Tongshu Gene Investments (1)
Tongshu Gene’s most recent deal was a Secondary Transaction - Private with Fangcheng Medical Laboratory. The deal was made on 29-Dec-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fangcheng Medical Laboratory | 29-Dec-2018 | Secondary Transaction - Private | Laboratory Services (Healthcare) |
Tongshu Gene FAQs
-
When was Tongshu Gene founded?
Tongshu Gene was founded in 2016.
-
Where is Tongshu Gene headquartered?
Tongshu Gene is headquartered in Changzhou, China.
-
What industry is Tongshu Gene in?
Tongshu Gene’s primary industry is Laboratory Services (Healthcare).
-
Is Tongshu Gene a private or public company?
Tongshu Gene is a Private company.
-
What is Tongshu Gene’s current revenue?
The current revenue for Tongshu Gene is .
-
How much funding has Tongshu Gene raised over time?
Tongshu Gene has raised $92.2M.
-
Who are Tongshu Gene’s investors?
Beijing Bohua Capital, China Galaxy Securities, GL Capital Group, Haier Financial Holdings, and Haier Group are 5 of 11 investors who have invested in Tongshu Gene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process